CD8A and neoplasm: These findings were made possible by the fact that the TGF antagonist was fused to the interferon Additionally, it has been demonstrated in a number of mouse models that intratumor delivery of TriMix mRNA that does not contain tumor-associated antigens activates CD8 + DCs and tumor-specific T lymphocytes, which in turn results in a delay in the growth of the tumor [259].